Press Release
BOSTON, MA and LONG ISLAND CITY, NY (November 19, 2026) – Parallel Fluidics and Opentrons Labworks, Inc. today announced a collaboration to bring Flow Processing Units (FPUs) to the Opentrons Flex liquid handling platform. Together, the companies are making it possible for any lab with an Opentrons Flex system to automate lipid nanoparticle (LNP) formulation, the drug delivery technology behind mRNA vaccines and other genetic medicines.
Opentrons has built the open foundation for AI-driven science, providing lab automation robots with open-source software and modular hardware that scientists can configure themselves. Parallel Fluidics builds on that foundation with FPUs: microfluidic-based, automation-native hardware designed to run directly on the Opentrons Flex deck. By combining the two, the companies are expanding what a single Opentrons Flex robot can do and giving scientists a more complete path from experimental design to results.
This collaboration introduces the first FPU available for the Opentrons Flex platform that automates LNP formulation. Leveraging the capabilities of the Opentrons Flex platform, scientists can now produce LNPs at 50X the throughput of common benchtop instruments, allowing teams to screen more formulations per study and identify lead drug candidates sooner. Further, because the entire workflow can now be run on a single, programmable platform, users can easily perform AI-driven experimentation and autonomous science to achieve results faster than ever before.
“Parallel Fluidics FPUs bring microfluidic workflows onto the Flex enabling scientists and AI agents to execute DOE-based LNP formulation campaigns,” said Leslie Mitchell, Ph.D., CSO of Opentrons. “LNP formulators no longer have to accept tradeoffs between the throughput of an automated workflow and the control of microfluidic mixing.”
“Opentrons gave every lab the ability to automate pipette-based workflows, and its open architecture is what made this collaboration possible,” said Joshua Gomes, CEO of Parallel Fluidics. “Together, we’re turning processes that once required a slow, manual instrument into something that runs natively on the Opentrons Flex.”
“Our lab is pairing new lipid chemistry with machine learning, which makes LNP development fundamentally a data problem,” said Marshall Padilla, Assistant Professor of Materials Science & Engineering at Stanford University. “With Parallel Fluidics FPUs, our Opentrons Flex becomes a single automated platform for formulating LNPs at the scale our characterization, biology, and predictive models demand.”
With an Opentrons Flex robot, labs can get started with ready-to-run LNP formulation protocols from the Opentrons® Protocol Library and a one-day training session from the Parallel Fluidics applications team. Parallel Fluidics plans to release additional FPUs in 2027 to address other process bottlenecks, including buffer exchange and antibody purification. Labs can learn more or request an evaluation at www.parallelfluidics.com/opentrons.
Parallel Fluidics builds Flow Processing Units (FPUs) to automate advanced lab workflows on the hardware already installed in every lab. The company is located in Boston, MA. Learn more at parallelfluidics.com.
Opentrons Labworks, Inc. builds the execution layer for autonomous science. Its open, API-driven laboratory robots standardize biological experimentation, creating a continuous learning loop between AI models and the physical lab. Opentrons currently has more than 11,000 robots deployed worldwide, including at every top-20 U.S. research university and 14 of the top 15 global biopharma companies. Founded in 2014 and headquartered in New York City, Opentrons is backed by Avego Management LLC, BroadOak Capital Partners, SoftBank, Khosla Ventures, Sands Capital, Lerer Hippeau and Y Combinator. Learn more at opentrons.com.
See how the LNP Screening Array runs reagent loading, formulation, and collection in a single automated workflow on the Flex deck.
Newsletter
Get new LNP application notes, protocols, and FPU releases for the Opentrons Flex in your inbox.